BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36142212)

  • 1. Histidine-Rich Glycoprotein Suppresses the S100A8/A9-Mediated Organotropic Metastasis of Melanoma Cells.
    Tomonobu N; Kinoshita R; Wake H; Inoue Y; Ruma IMW; Suzawa K; Gohara Y; Komalasari NLGY; Jiang F; Murata H; Yamamoto KI; Sumardika IW; Chen Y; Futami J; Yamauchi A; Kuribayashi F; Kondo E; Toyooka S; Nishibori M; Sakaguchi M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow.
    Tomonobu N; Kinoshita R; Sakaguchi M
    Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
    Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
    Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.
    Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
    Int J Cancer; 2019 Jun; 144(12):3138-3145. PubMed ID: 30365872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis.
    Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
    Int J Cancer; 2019 Jul; 145(2):569-575. PubMed ID: 30414170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-1,3-Galactosyl-
    Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
    Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
    Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C
    J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroplastin-β mediates S100A8/A9-induced lung cancer disseminative progression.
    Sumardika IW; Chen Y; Tomonobu N; Kinoshita R; Ruma IMW; Sato H; Kondo E; Inoue Y; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Putranto EW; Hibino T; Nishibori M; Toyooka S; Sakaguchi M
    Mol Carcinog; 2019 Jun; 58(6):980-995. PubMed ID: 30720226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum.
    Duvetorp A; Söderman J; Assarsson M; Skarstedt M; Svensson Å; Seifert O
    PLoS One; 2019; 14(3):e0213344. PubMed ID: 30865695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
    Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
    Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
    McNeill E; Hogg N
    Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of S100A8/A9 for Cytokine Secretion, Revealed in Neutrophils Derived from ER-Hoxb8 Progenitors.
    Zhou Y; Hann J; Schenten V; Plançon S; Bueb JL; Tolle F; Bréchard S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
    Grebhardt S; Veltkamp C; Ströbel P; Mayer D
    Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8 and S100A9 in Cancer.
    Chen Y; Ouyang Y; Li Z; Wang X; Ma J
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of S100A8/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling.
    Kuipers MT; Vogl T; Aslami H; Jongsma G; van den Berg E; Vlaar AP; Roelofs JJ; Juffermans NP; Schultz MJ; van der Poll T; Roth J; Wieland CW
    PLoS One; 2013; 8(7):e68694. PubMed ID: 23874727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
    Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
    Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
    Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
    J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.